市值: $3.273T 0.720%
成交额(24h): $115.5487B -20.290%
  • 市值: $3.273T 0.720%
  • 成交额(24h): $115.5487B -20.290%
  • 恐惧与贪婪指数:
  • 市值: $3.273T 0.720%
加密货币
话题
百科
资讯
加密话题
视频
热门新闻
加密货币
话题
百科
资讯
加密话题
视频
bitcoin
bitcoin

$106554.015123 USD

1.63%

ethereum
ethereum

$2453.720517 USD

2.48%

tether
tether

$1.000504 USD

-0.01%

xrp
xrp

$2.184729 USD

2.30%

bnb
bnb

$645.072770 USD

0.97%

solana
solana

$146.042618 USD

2.39%

usd-coin
usd-coin

$0.999904 USD

0.00%

tron
tron

$0.273125 USD

0.17%

dogecoin
dogecoin

$0.166374 USD

2.51%

cardano
cardano

$0.586207 USD

1.45%

hyperliquid
hyperliquid

$38.596053 USD

4.50%

sui
sui

$2.807444 USD

1.32%

bitcoin-cash
bitcoin-cash

$473.606870 USD

3.34%

chainlink
chainlink

$13.383890 USD

3.88%

unus-sed-leo
unus-sed-leo

$9.032885 USD

-1.05%

加密货币新闻

葡萄牙的疫苗接种成功:保护儿童健康

2025/06/25 22:02

葡萄牙在儿童中保持高疫苗接种率,关键疾病的疫苗接种率超过95%,并展示了有效的公共卫生策略。

葡萄牙的疫苗接种成功:保护儿童健康

Portugal's Vaccination Success: Protecting Children's Health

葡萄牙的疫苗接种成功:保护儿童健康

Portugal is setting a high bar when it comes to keeping its kids healthy. With vaccination coverage rates consistently hitting or exceeding 95% for children up to six years old, the country is demonstrating a real commitment to public health. Let's dive into the details.

葡萄牙在保持孩子健康方面正在设置高标准。随着疫苗接种率始终达到或超过六岁的儿童的95%,该国表现出对公共卫生的真正承诺。让我们研究细节。

Impressive Coverage Rates

令人印象深刻的覆盖率

The 2024 annual report from the Directorate-General for Health (DGS) paints a reassuring picture. Not only are the overall vaccination rates stellar, but specific areas show remarkable progress. For instance, a whopping 86% of babies born between August 2024 and March 2025 were vaccinated against the Respiratory Syncytial Virus (RSV) during the initial immunization campaign. This impressive figure has significantly reduced hospitalizations for infants under six months.

卫生总局(DGS)2024年的年度报告令人放心。总体疫苗接种率不仅出色,而且特定领域的进展显着。例如,在2024年8月至2025年3月之间出生的婴儿中有86%的婴儿在最初的免疫运动期间接种了呼吸道合胞病毒(RSV)的疫苗接种。这一令人印象深刻的数字大大减少了六个月以下婴儿的住院治疗。

Measles, Mumps, and Rubella (MMR) on the Rise

麻疹,腮腺炎和风疹(MMR)上升

Portugal is also making strides in MMR vaccination. Coverage for the first and second doses has increased between 2023 and 2024, reaching 99% in two-year-olds and 96% in six-year-olds. These numbers reflect a sustained effort to protect children from these highly contagious diseases.

葡萄牙也在MMR疫苗接种方面取得了长足进步。在2023年至2024年之间,第一剂和第二剂的覆盖范围增加了,两岁的孩子的覆盖量达到99%,六岁的孩子达到了96%。这些数字反映了保护儿童免受这些高度传染性疾病的持续努力。

HPV Vaccination: Closing the Gender Gap

HPV疫苗接种:缩小性别差距

Vaccination against HPV (human papillomavirus) is another success story. Coverage in girls remains high, surpassing the 90% target. Even better, the trend of increasing vaccination rates in boys is continuing, with coverage in 15-year-old boys also exceeding 90%. This is a big step towards achieving comprehensive protection against HPV-related illnesses.

针对HPV(人乳头瘤病毒)的疫苗接种是另一个成功的故事。女孩的覆盖范围仍然很高,超过了90%的目标。更好的是,男孩的疫苗接种率提高的趋势仍在继续,15岁男孩的覆盖范围也超过90%。这是朝着全面保护与HPV相关疾病的全面保护的重要一步。

Other Key Vaccines

其他关键疫苗

The combined vaccine against tetanus, diphtheria, pertussis, and polio (DTPaVIP) achieved a coverage rate of 93% in six-year-olds. For the N. meningitidis serogroup B (MenB) vaccine, 97% of two-year-olds received the complete three-dose schedule. These figures highlight Portugal's dedication to protecting children from a wide range of preventable diseases.

六岁的疫苗对破伤风,白喉,百日咳和小儿麻痹症(DTPAVIP)的疫苗合并为六岁的覆盖率为93%。对于N.脑膜炎血清群B(MENB)疫苗,两岁的孩子中有97%接受了完整的三剂时间表。这些数字强调了葡萄牙致力于保护儿童免受多种可预防疾病的侵害。

Vaccination During Pregnancy

怀孕期间的疫苗接种

Vaccination against whooping cough during pregnancy is also a priority, with approximately 80.4% of eligible pregnant women receiving the Tdpa vaccine in 2024. This strategy helps protect newborns during their first few months of life, before they can be fully vaccinated themselves.

怀孕期间针对百日咳的疫苗接种也是一个优先事项,2024年,约有80.4%的符合条件的孕妇接受TDPA疫苗。该策略有助于在他们的头几个月生命中保护新生儿,然后才能完全接种疫苗。

Addressing Adverse Reactions

解决不良反应

While the overall picture is positive, it's important to acknowledge that adverse reactions to vaccines can occur. In 2024, there were 370 reported cases of suspected adverse reactions, which translates to about 12.8 cases per 100,000 vaccines administered. The DGS emphasizes that reporting a suspected adverse reaction doesn't automatically imply a causal relationship and that each case undergoes a thorough technical assessment.

尽管整体情况是积极的,但必须承认可能会对疫苗产生不利反应。在2024年,有370例可疑的不良反应病例,转化为每10万疫苗约12.8例。 DGS强调,报告可疑的不良反应并不意味着因果关系,并且每种情况都会进行彻底的技术评估。

Municipal-Level Data for Targeted Action

针对目标行动的市政级别数据

For the first time, the 2024 report includes vaccination results broken down by municipality. This level of detail allows health professionals and other stakeholders to identify geographic areas where vaccination rates may be lower and to develop targeted interventions.

2024年的报告首次包括市政当局分解的疫苗接种结果。这种详细信息使卫生专业人员和其他利益相关者能够确定疫苗接种率可能较低并制定有针对性干预措施的地理区域。

Seasonal Vaccination Campaigns

季节性疫苗接种运动

Portugal's commitment to vaccination extends beyond routine childhood immunizations. The autumn-winter 2024-2025 seasonal vaccination campaign saw almost 4 million vaccines administered in SNS units and community pharmacies. A high-dose flu vaccine was introduced for those 85 and over, achieving high vaccination coverage.

葡萄牙对疫苗接种的承诺超出了常规的儿童免疫接种。秋冬2024-2025季节性疫苗接种运动中,SNS单元和社区药房施用了近400万次疫苗。引入了85岁及以上的高剂量流感疫苗,可实现高疫苗接种覆盖率。

Final Thoughts

最后的想法

Portugal's proactive approach to vaccination is clearly paying off, safeguarding the health of its youngest citizens. By maintaining high coverage rates and continually refining its strategies, the country is setting an example for others to follow. It's all about keeping those little ones healthy and thriving!

葡萄牙的积极疫苗接种方法显然正在获得回报,从而保护了其最年轻的公民的健康。通过保持较高的覆盖率并不断完善其策略,该国为其他人树立了一个榜样。一切都是为了使这些小孩子保持健康和繁荣!

免责声明:info@kdj.com

所提供的信息并非交易建议。根据本文提供的信息进行的任何投资,kdj.com不承担任何责任。加密货币具有高波动性,强烈建议您深入研究后,谨慎投资!

如您认为本网站上使用的内容侵犯了您的版权,请立即联系我们(info@kdj.com),我们将及时删除。

2025年06月26日 发表的其他文章